INTRODUCTION: We investigated the effects of maternal @entity299 ( @entity6015 ) on pregnancy outcomes in anti-Ro/SSA-positive @entity1 and assessed the population-based incidence of @entity616 . MATERIAL AND METHODS: Hundred and ninety nine anti-Ro/SSA-positive pregnancies were prospectively followed at our center (2000-2013). Seven fetuses developed @entity713 ( @entity713 ) II-III. In this period, another 13 anti-Ro/SSA-positive pregnancies were referred for fetal @entity1168 , subsequently diagnosed with @entity713 II-III. Cesarean section rates, gestational age, body measurements at birth, and the incidence of @entity6015 in these 212 pregnancies were analyzed in relation to fetal atrioventricular conduction and maternal diagnosis and compared with data from the Medical Birth Registry on 352 104 pregnancies in the Stockholm County. RESULTS: The prevalence of maternal @entity1252 ( @entity1252 ) and primary Sj  gren's syndrome and the outcomes at birth were similar in normal conduction and @entity713 I cases. Only 1/20 @entity713 II-III cases (0/7 in the surveillance group) had a mother diagnosed with @entity1252 , compared with 73/192 in cases with normal conduction or @entity713 I. Excluding cases with @entity713 II-III, @entity1252 mothers more frequently delivered by cesarean section (31% vs. 20%, p < 0.05) and had a higher incidence of @entity600 (13% vs. 5.8%, p < 0.05) than the county population. Both @entity1252 and primary Sj  gren's syndrome mothers had a fourfold greater rate of growth-retarded babies (10.11% vs. 2.2%, p < 0.001). The incidence of autoantibody-related @entity713 II-III in Stockholm County was 1/23 300. CONCLUSION: This study of @entity6015 provides new information on the incidence of @entity6015 and outcome of pregnancy in anti-Ro/SSA-positive @entity1 , which has clinical relevance when counseling @entity627 @entity1 considering pregnancy.

Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity627 :: ('MESH:D012216', 'Disease') :: ['rheumatic'] @entity713 :: ('MESH:D054537', 'Disease') :: ['atrioventricular block', 'AVB'] @entity1168 :: ('MESH:D001919', 'Disease') :: ['bradycardia'] @entity1252 :: ('MESH:D008180', 'Disease') :: ['SLE', 'systemic lupus erythematosus'] @entity600 :: ('MESH:D000014', 'Disease') :: ['preterm birth'] @entity299 :: ('MESH:D006331', 'Disease') :: ['autoimmune disease and fetal congenital heart block'] @entity6015 :: ('MESH:C535758', 'Disease') :: ['CHB'] @entity616 :: ('MESH:D006327', 'Disease') :: ['isolated CHB']
@entity6015 :: (MESH:C535758,Disease) :: ['congenital heart block']
